Adult Genetics Clinic
Adult Cancer Genetics Clinic
Cardiovascular Genetics Clinic
Metabolic Clinic
Neurofibromatosis Clinic
Pediatric Genetics Clinic
Prenatal Genetics Clinic
Skeletal Dysplasia Clinic
Clinical Genetics Faculty
Medical Genetic Program
Back to Department Home Page
Back to Clinical Genetics Home Page

 Amniocentesis 

Who Should Consider Amniocentesis?
Amniocentesis should generally be considered by women age 35 or older at the time of delivery, individuals who have had a child with a chromosome abnormality, individuals who have a chromosome translocation or other rearrangement, couples at risk for a prenatally diagnosable genetic disease (e.g., hemophilia, sickle cell disease, or cystic fibrosis), and individuals with a child or other close family members with a neural tube defect (spina bifida or anencephaly). Amniocentesis may also be considered when certain abnormalities are seen on ultrasound or when maternal serum screening has identified an increased risk for fetal anomalies.

How Is Amniocentesis Performed?
An ultrasound evaluation is performed to assess fetal development, to locate the placenta, to determine fetal age, and to select a pocket of amniotic fluid. A site is identified on the woman's abdomen and with ultrasound guidance, a thin needle is inserted through the abdomen and into the uterus. A small amount of amniotic fluid is removed and sent to be analyzed.

Does The Procedure Hurt?
Most women describe the procedure as mildly uncomfortable. Some women do experience cramping after the test. Most women are able to return to normal activities shortly after the test.

What Is The Risk of Miscarriage After Amniocentesis?
The most common complications are vaginal spotting or bleeding, severe cramping, or miscarriage. Maternal infection is rare. The procedure-related risk for any complication, including miscarriage, is approximately 1 in 200.

What Is Analyzed From Amniocentesis?
Cells shed from the amnion (the sac surrounding the fetus), fetal skin, and gastrointestinal tract are normally floating in the amniotic fluid. These cells can be grown (cultured) in the laboratory. Chromosome analysis is performed on these cultured cells. AFP (alpha-fetoprotein) is also present in the amniotic fluid and is measured.

What Can Be Detected Through Amniocentesis?
Chromosome abnormalities (such as Down syndrome) can be detected through amniocentesis. The majority of neural tube defects are detected by elevated levels of AFP in the amniotic fluid. Some specific genetic disease can be diagnosed by DNA or enzyme analysis if indicated.

No method of prenatal testing can guarantee a baby will be born without birth defects or genetic disease. Prenatal testing can only identify the diagnosable problems for which a couple is known to be at risk. Unfortunately, there are many conditions for which prenatal diagnosis is not yet available.

How Accurate Are The Results from Amniocentesis?
Chromosome results are greater than 99% accurate. Measurement of the amniotic fluid AFP is greater than 96% accurate in detecting neural tube defects. Occasionally, results need to be clarified through blood tests on the parents, ultrasound, a repeat amniocentesis, or fetal blood sampling.

How Long Do The Results Take?
Chromosome and amniotic fluid AFP results take approximately 2 weeks for completion. Special studies for other genetic diseases may take longer.  Patients who elect to have an aneuploidy FISH test on their sample can receive those results in 24-48 hours from the day of the procedure.


Go back to Department home page Link to BCM Public Site